213 related articles for article (PubMed ID: 35031599)
1. NEK2 enhances malignancies of glioblastoma via NIK/NF-κB pathway.
Xiang J; Alafate W; Wu W; Wang Y; Li X; Xie W; Bai X; Li R; Wang M; Wang J
Cell Death Dis; 2022 Jan; 13(1):58. PubMed ID: 35031599
[TBL] [Abstract][Full Text] [Related]
2. Loss of PLK2 induces acquired resistance to temozolomide in GBM via activation of notch signaling.
Alafate W; Xu D; Wu W; Xiang J; Ma X; Xie W; Bai X; Wang M; Wang J
J Exp Clin Cancer Res; 2020 Nov; 39(1):239. PubMed ID: 33176854
[TBL] [Abstract][Full Text] [Related]
3. Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway.
Yu X; Wang M; Zuo J; Wahafu A; Mao P; Li R; Wu W; Xie W; Wang J
Life Sci; 2019 Nov; 236():116917. PubMed ID: 31614149
[TBL] [Abstract][Full Text] [Related]
4. CRB2 enhances malignancy of glioblastoma via activation of the NF-κB pathway.
Wang Y; Bao G; Zhang M; Xiang J; Zhou H; Wahafu A; Wu W; Ma X; Huo L; Bai X; Xie W; Liu P; Wang M
Exp Cell Res; 2022 May; 414(1):113077. PubMed ID: 35219647
[TBL] [Abstract][Full Text] [Related]
5. Histone lactylation-derived LINC01127 promotes the self-renewal of glioblastoma stem cells via the cis-regulating the MAP4K4 to activate JNK pathway.
Li L; Li Z; Meng X; Wang X; Song D; Liu Y; Xu T; Qin J; Sun N; Tian K; Zhong J; Yu D; Song Y; Hou T; Jiang C; Chen Q; Cai J
Cancer Lett; 2023 Nov; 579():216467. PubMed ID: 38084701
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) promotes glioma cell invasion through induction of NF-κB-inducing kinase (NIK) and noncanonical NF-κB signaling.
Cherry EM; Lee DW; Jung JU; Sitcheran R
Mol Cancer; 2015 Jan; 14(1):9. PubMed ID: 25622756
[TBL] [Abstract][Full Text] [Related]
7. Identification of non-canonical NF-κB signaling as a critical mediator of Smac mimetic-stimulated migration and invasion of glioblastoma cells.
Tchoghandjian A; Jennewein C; Eckhardt I; Rajalingam K; Fulda S
Cell Death Dis; 2013 Mar; 4(3):e564. PubMed ID: 23538445
[TBL] [Abstract][Full Text] [Related]
8. Hepatoma cell functions modulated by NEK2 are associated with liver cancer progression.
Wu SM; Lin SL; Lee KY; Chuang HC; Feng PH; Cheng WL; Liao CJ; Chi HC; Lin YH; Tsai CY; Chen WJ; Yeh CT; Lin KH
Int J Cancer; 2017 Apr; 140(7):1581-1596. PubMed ID: 27925179
[TBL] [Abstract][Full Text] [Related]
9. Polo‑like kinase 4 promotes tumorigenesis and induces resistance to radiotherapy in glioblastoma.
Wang J; Zuo J; Wang M; Ma X; Gao K; Bai X; Wang N; Xie W; Liu H
Oncol Rep; 2019 Apr; 41(4):2159-2167. PubMed ID: 30816483
[TBL] [Abstract][Full Text] [Related]
10. S100A11 functions as novel oncogene in glioblastoma via S100A11/ANXA2/NF-κB positive feedback loop.
Tu Y; Xie P; Du X; Fan L; Bao Z; Sun G; Zhao P; Chao H; Li C; Zeng A; Pan M; Ji J
J Cell Mol Med; 2019 Oct; 23(10):6907-6918. PubMed ID: 31430050
[TBL] [Abstract][Full Text] [Related]
11. CXCL5 promotes tumorigenesis and angiogenesis of glioblastoma via JAK-STAT/NF-κb signaling pathways.
Mao P; Wang T; Du CW; Yu X; Wang MD
Mol Biol Rep; 2023 Oct; 50(10):8015-8023. PubMed ID: 37541997
[TBL] [Abstract][Full Text] [Related]
12. Targeting NEK2 impairs oncogenesis and radioresistance via inhibiting the Wnt1/β-catenin signaling pathway in cervical cancer.
Xu T; Zeng Y; Shi L; Yang Q; Chen Y; Wu G; Li G; Xu S
J Exp Clin Cancer Res; 2020 Sep; 39(1):183. PubMed ID: 32907622
[TBL] [Abstract][Full Text] [Related]
13. NF-κB-induced IL-6 ensures STAT3 activation and tumor aggressiveness in glioblastoma.
McFarland BC; Hong SW; Rajbhandari R; Twitty GB; Gray GK; Yu H; Benveniste EN; Nozell SE
PLoS One; 2013; 8(11):e78728. PubMed ID: 24244348
[TBL] [Abstract][Full Text] [Related]
14. CCNA2 and NEK2 regulate glioblastoma progression by targeting the cell cycle.
Zhou HY; Wang YC; Wang T; Wu W; Cao YY; Zhang BC; Wang MD; Mao P
Oncol Lett; 2024 May; 27(5):206. PubMed ID: 38516683
[TBL] [Abstract][Full Text] [Related]
15. Destabilizing NEK2 overcomes resistance to proteasome inhibition in multiple myeloma.
Franqui-Machin R; Hao M; Bai H; Gu Z; Zhan X; Habelhah H; Jethava Y; Qiu L; Frech I; Tricot G; Zhan F
J Clin Invest; 2018 Jul; 128(7):2877-2893. PubMed ID: 29863498
[TBL] [Abstract][Full Text] [Related]
16. Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2.
Wang J; Cheng P; Pavlyukov MS; Yu H; Zhang Z; Kim SH; Minata M; Mohyeldin A; Xie W; Chen D; Goidts V; Frett B; Hu W; Li H; Shin YJ; Lee Y; Nam DH; Kornblum HI; Wang M; Nakano I
J Clin Invest; 2017 Aug; 127(8):3075-3089. PubMed ID: 28737508
[TBL] [Abstract][Full Text] [Related]
17. A DNA methylation prognostic signature of glioblastoma: identification of NPTX2-PTEN-NF-κB nexus.
Shukla S; Pia Patric IR; Thinagararjan S; Srinivasan S; Mondal B; Hegde AS; Chandramouli BA; Santosh V; Arivazhagan A; Somasundaram K
Cancer Res; 2013 Nov; 73(22):6563-73. PubMed ID: 24078801
[TBL] [Abstract][Full Text] [Related]
18. IKBKE enhances TMZ-chemoresistance through upregulation of MGMT expression in glioblastoma.
Guo G; Sun Y; Hong R; Xiong J; Lu Y; Liu Y; Lu J; Zhang Z; Guo C; Nan Y; Huang Q
Clin Transl Oncol; 2020 Aug; 22(8):1252-1262. PubMed ID: 31865606
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional induction of NF-κB-inducing kinase by E2F4/5 facilitates collective invasion of GBM cells.
Pflug KM; Lee DW; McFadden K; Herrera L; Sitcheran R
Sci Rep; 2023 Aug; 13(1):13093. PubMed ID: 37567906
[TBL] [Abstract][Full Text] [Related]
20. The Recent Research Progress of NF-κB Signaling on the Proliferation, Migration, Invasion, Immune Escape and Drug Resistance of Glioblastoma.
Shi P; Xu J; Cui H
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
